Sio Capital Management, LLC Merus N.V. Transaction History

Sio Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$14.25 - $20.5 $1.03 Million - $1.48 Million	-72,389 Reduced 82.3%	15,564 $286,000
Q2 2022 Aug 15, 2022	SELL	$13.98 - $29.25 $28,617 - $59,874	-2,047 Reduced 2.27%	87,953 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $1.8 Million - $2.91 Million	90,000 New	90,000 $2.86 Million

200

62M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.88B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.